Kidney cancer, version 3.2015: Featured updates to the NCCN guidelines

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Clair Beard, Sam Bhayani, Graeme B. Bolger, Sam S. Chang, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Shilpa Gupta, Steven L. Hancock, Jenny J. Kim, Timothy M. Kuzel, Elaine T. Lam, Clayton Lau, Ellis G. Levine, Daniel W. Lin, M. Dror Michaelson, Thomas OlenckiRoberto Pili, Elizabeth R. Plimack, Edward N. Rampersaud, Bruce G. Redman, Charles J. Ryan, Joel Sheinfeld, Brian Shuch, Kanishka Sircar, Brad Somer, Richard B. Wilder, Mary Dwyer, Rashmi Kumar

Research output: Contribution to journalReview article

153 Citations (Scopus)

Abstract

The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These NCCN Guidelines Insights highlight the recent updates/changes in these guidelines, and updates include axitinib as first-line treatment option for patients with clear cell renal carcinoma, new data to support pazopanib as subsequent therapy for patients with clear cell carcinoma after first-line treatment with another tyrosine kinase inhibitor, and guidelines for follow-up of patients with renal cell carcinoma.

Original languageEnglish (US)
Pages (from-to)151-159
Number of pages9
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume13
Issue number2
StatePublished - Feb 1 2015
Externally publishedYes

Fingerprint

Kidney Neoplasms
Renal Cell Carcinoma
Guidelines
Protein-Tyrosine Kinases
Therapeutics
Carcinoma

ASJC Scopus subject areas

  • Oncology
  • Medicine(all)

Cite this

Motzer, R. J., Jonasch, E., Agarwal, N., Beard, C., Bhayani, S., Bolger, G. B., ... Kumar, R. (2015). Kidney cancer, version 3.2015: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 13(2), 151-159.

Kidney cancer, version 3.2015 : Featured updates to the NCCN guidelines. / Motzer, Robert J.; Jonasch, Eric; Agarwal, Neeraj; Beard, Clair; Bhayani, Sam; Bolger, Graeme B.; Chang, Sam S.; Choueiri, Toni K.; Costello, Brian A.; Derweesh, Ithaar H.; Gupta, Shilpa; Hancock, Steven L.; Kim, Jenny J.; Kuzel, Timothy M.; Lam, Elaine T.; Lau, Clayton; Levine, Ellis G.; Lin, Daniel W.; Michaelson, M. Dror; Olencki, Thomas; Pili, Roberto; Plimack, Elizabeth R.; Rampersaud, Edward N.; Redman, Bruce G.; Ryan, Charles J.; Sheinfeld, Joel; Shuch, Brian; Sircar, Kanishka; Somer, Brad; Wilder, Richard B.; Dwyer, Mary; Kumar, Rashmi.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 13, No. 2, 01.02.2015, p. 151-159.

Research output: Contribution to journalReview article

Motzer, RJ, Jonasch, E, Agarwal, N, Beard, C, Bhayani, S, Bolger, GB, Chang, SS, Choueiri, TK, Costello, BA, Derweesh, IH, Gupta, S, Hancock, SL, Kim, JJ, Kuzel, TM, Lam, ET, Lau, C, Levine, EG, Lin, DW, Michaelson, MD, Olencki, T, Pili, R, Plimack, ER, Rampersaud, EN, Redman, BG, Ryan, CJ, Sheinfeld, J, Shuch, B, Sircar, K, Somer, B, Wilder, RB, Dwyer, M & Kumar, R 2015, 'Kidney cancer, version 3.2015: Featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 13, no. 2, pp. 151-159.
Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB et al. Kidney cancer, version 3.2015: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network. 2015 Feb 1;13(2):151-159.
Motzer, Robert J. ; Jonasch, Eric ; Agarwal, Neeraj ; Beard, Clair ; Bhayani, Sam ; Bolger, Graeme B. ; Chang, Sam S. ; Choueiri, Toni K. ; Costello, Brian A. ; Derweesh, Ithaar H. ; Gupta, Shilpa ; Hancock, Steven L. ; Kim, Jenny J. ; Kuzel, Timothy M. ; Lam, Elaine T. ; Lau, Clayton ; Levine, Ellis G. ; Lin, Daniel W. ; Michaelson, M. Dror ; Olencki, Thomas ; Pili, Roberto ; Plimack, Elizabeth R. ; Rampersaud, Edward N. ; Redman, Bruce G. ; Ryan, Charles J. ; Sheinfeld, Joel ; Shuch, Brian ; Sircar, Kanishka ; Somer, Brad ; Wilder, Richard B. ; Dwyer, Mary ; Kumar, Rashmi. / Kidney cancer, version 3.2015 : Featured updates to the NCCN guidelines. In: JNCCN Journal of the National Comprehensive Cancer Network. 2015 ; Vol. 13, No. 2. pp. 151-159.
@article{b2596b68527345058489755ce2a961a5,
title = "Kidney cancer, version 3.2015: Featured updates to the NCCN guidelines",
abstract = "The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These NCCN Guidelines Insights highlight the recent updates/changes in these guidelines, and updates include axitinib as first-line treatment option for patients with clear cell renal carcinoma, new data to support pazopanib as subsequent therapy for patients with clear cell carcinoma after first-line treatment with another tyrosine kinase inhibitor, and guidelines for follow-up of patients with renal cell carcinoma.",
author = "Motzer, {Robert J.} and Eric Jonasch and Neeraj Agarwal and Clair Beard and Sam Bhayani and Bolger, {Graeme B.} and Chang, {Sam S.} and Choueiri, {Toni K.} and Costello, {Brian A.} and Derweesh, {Ithaar H.} and Shilpa Gupta and Hancock, {Steven L.} and Kim, {Jenny J.} and Kuzel, {Timothy M.} and Lam, {Elaine T.} and Clayton Lau and Levine, {Ellis G.} and Lin, {Daniel W.} and Michaelson, {M. Dror} and Thomas Olencki and Roberto Pili and Plimack, {Elizabeth R.} and Rampersaud, {Edward N.} and Redman, {Bruce G.} and Ryan, {Charles J.} and Joel Sheinfeld and Brian Shuch and Kanishka Sircar and Brad Somer and Wilder, {Richard B.} and Mary Dwyer and Rashmi Kumar",
year = "2015",
month = "2",
day = "1",
language = "English (US)",
volume = "13",
pages = "151--159",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "2",

}

TY - JOUR

T1 - Kidney cancer, version 3.2015

T2 - Featured updates to the NCCN guidelines

AU - Motzer, Robert J.

AU - Jonasch, Eric

AU - Agarwal, Neeraj

AU - Beard, Clair

AU - Bhayani, Sam

AU - Bolger, Graeme B.

AU - Chang, Sam S.

AU - Choueiri, Toni K.

AU - Costello, Brian A.

AU - Derweesh, Ithaar H.

AU - Gupta, Shilpa

AU - Hancock, Steven L.

AU - Kim, Jenny J.

AU - Kuzel, Timothy M.

AU - Lam, Elaine T.

AU - Lau, Clayton

AU - Levine, Ellis G.

AU - Lin, Daniel W.

AU - Michaelson, M. Dror

AU - Olencki, Thomas

AU - Pili, Roberto

AU - Plimack, Elizabeth R.

AU - Rampersaud, Edward N.

AU - Redman, Bruce G.

AU - Ryan, Charles J.

AU - Sheinfeld, Joel

AU - Shuch, Brian

AU - Sircar, Kanishka

AU - Somer, Brad

AU - Wilder, Richard B.

AU - Dwyer, Mary

AU - Kumar, Rashmi

PY - 2015/2/1

Y1 - 2015/2/1

N2 - The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These NCCN Guidelines Insights highlight the recent updates/changes in these guidelines, and updates include axitinib as first-line treatment option for patients with clear cell renal carcinoma, new data to support pazopanib as subsequent therapy for patients with clear cell carcinoma after first-line treatment with another tyrosine kinase inhibitor, and guidelines for follow-up of patients with renal cell carcinoma.

AB - The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These NCCN Guidelines Insights highlight the recent updates/changes in these guidelines, and updates include axitinib as first-line treatment option for patients with clear cell renal carcinoma, new data to support pazopanib as subsequent therapy for patients with clear cell carcinoma after first-line treatment with another tyrosine kinase inhibitor, and guidelines for follow-up of patients with renal cell carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=84923445330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923445330&partnerID=8YFLogxK

M3 - Review article

C2 - 25691606

AN - SCOPUS:84923445330

VL - 13

SP - 151

EP - 159

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 2

ER -